Glytec Receives 510(k) Approval for Diabetes Management Software

August 17, 2017

Glytec announced its fourth FDA 510(k) clearance, adding additional capabilities to its Glucommander diabetes management system.

The latest approval encompasses a titration module for inpatients undergoing enteral nutrition, an insulin-to-carb ratio titration option for outpatients, more flexible messaging for dose adjustments, and improved workflow capabilities.

The company claims the platform delivers safety improvements and annual savings as high as $20,000 per licensed acute care bed.

View today's stories